ATE320254T1 - Crf receptor antagonisten - Google Patents

Crf receptor antagonisten

Info

Publication number: ATE320254T1
Authority: AT; Austria
Prior art keywords: receptor antagonists; crf receptor; crf; antagonists; receptor
Prior art date: 2001-04-30

Application number

AT02718405T

Other languages

English (en)

Inventor

Fabio Romano Di

Fabrizio Micheli

Alessandra Pasquarello

Yves St-Denis

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-30

Filing date

2002-04-30

Publication date

2006-04-15

2001-04-30 Priority claimed from GB0110579A external-priority patent/GB0110579D0/en

2001-04-30 Priority claimed from GB0110566A external-priority patent/GB0110566D0/en

2001-07-17 Priority claimed from GB0117423A external-priority patent/GB0117423D0/en

2002-02-11 Priority claimed from GB0203203A external-priority patent/GB0203203D0/en

2002-04-30 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE320254T1 publication Critical patent/ATE320254T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT02718405T 2001-04-30 2002-04-30 Crf receptor antagonisten ATE320254T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0110579A GB0110579D0 (en)	2001-04-30	2001-04-30	Chemical compounds
GB0110566A GB0110566D0 (en)	2001-04-30	2001-04-30	Chemical compounds
GB0117423A GB0117423D0 (en)	2001-07-17	2001-07-17	Chemical compounds
GB0203203A GB0203203D0 (en)	2002-02-11	2002-02-11	Chemical compounds

Publications (1)

Publication Number	Publication Date
ATE320254T1 true ATE320254T1 (de)	2006-04-15

Family

ID=27447943

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02718405T ATE320254T1 (de)	2001-04-30	2002-04-30	Crf receptor antagonisten

Country Status (21)

Country	Link
US (1)	US7329667B2 (de)
EP (1)	EP1383498B1 (de)
JP (1)	JP2004528342A (de)
KR (1)	KR20040015205A (de)
CN (1)	CN1512883A (de)
AR (1)	AR033296A1 (de)
AT (1)	ATE320254T1 (de)
AU (1)	AU2002249474B2 (de)
BR (1)	BR0209035A (de)
CA (1)	CA2446497A1 (de)
CZ (1)	CZ20032945A3 (de)
DE (1)	DE60209885T2 (de)
ES (1)	ES2255610T3 (de)
HU (1)	HUP0304035A2 (de)
IL (1)	IL158063A0 (de)
MX (1)	MXPA03009930A (de)
NO (1)	NO20034837L (de)
NZ (1)	NZ528364A (de)
PL (1)	PL366854A1 (de)
TW (1)	TWI236908B (de)
WO (1)	WO2002087573A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
CA2764885C (en)	2009-06-08	2018-05-15	Takeda Pharmaceutical Company Limited	Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
RU2498986C2 (ru) *	2011-07-20	2013-11-20	Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран)	ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403599B1 (en) *	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
ZA973884B (en)	1996-05-23	1998-11-06	Du Pont Merck Pharma	Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
ES2180338T3 (es) *	1998-11-12	2003-02-01	Neurocrine Biosciences Inc	Antagonistas del receptor de crf y metodos relacionados.
JP2002529469A (ja) *	1998-11-12	2002-09-10	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	Ｃｒｆレセプターアンタゴニストおよびそれに関する方法
GB0117395D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds

2002
- 2002-04-30 CN CNA028107454A patent/CN1512883A/zh active Pending
- 2002-04-30 DE DE60209885T patent/DE60209885T2/de not_active Expired - Fee Related
- 2002-04-30 US US10/476,441 patent/US7329667B2/en not_active Expired - Fee Related
- 2002-04-30 EP EP02718405A patent/EP1383498B1/de not_active Expired - Lifetime
- 2002-04-30 JP JP2002584918A patent/JP2004528342A/ja active Pending
- 2002-04-30 BR BR0209035-0A patent/BR0209035A/pt not_active IP Right Cessation
- 2002-04-30 ES ES02718405T patent/ES2255610T3/es not_active Expired - Lifetime
- 2002-04-30 TW TW091108900A patent/TWI236908B/zh not_active IP Right Cessation
- 2002-04-30 IL IL15806302A patent/IL158063A0/xx unknown
- 2002-04-30 CA CA002446497A patent/CA2446497A1/en not_active Abandoned
- 2002-04-30 KR KR10-2003-7014159A patent/KR20040015205A/ko not_active Application Discontinuation
- 2002-04-30 HU HU0304035A patent/HUP0304035A2/hu unknown
- 2002-04-30 PL PL02366854A patent/PL366854A1/xx not_active Application Discontinuation
- 2002-04-30 AR ARP020101598A patent/AR033296A1/es unknown
- 2002-04-30 AU AU2002249474A patent/AU2002249474B2/en not_active Ceased
- 2002-04-30 CZ CZ20032945A patent/CZ20032945A3/cs unknown
- 2002-04-30 NZ NZ528364A patent/NZ528364A/en unknown
- 2002-04-30 AT AT02718405T patent/ATE320254T1/de not_active IP Right Cessation
- 2002-04-30 MX MXPA03009930A patent/MXPA03009930A/es active IP Right Grant
- 2002-04-30 WO PCT/GB2002/001981 patent/WO2002087573A1/en active IP Right Grant
2003
- 2003-10-29 NO NO20034837A patent/NO20034837L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1383498A1 (de)	2004-01-28
CA2446497A1 (en)	2002-11-07
AR033296A1 (es)	2003-12-10
EP1383498B1 (de)	2006-03-15
PL366854A1 (en)	2005-02-07
WO2002087573A1 (en)	2002-11-07
JP2004528342A (ja)	2004-09-16
MXPA03009930A (es)	2004-01-29
HUP0304035A2 (hu)	2004-04-28
AU2002249474B2 (en)	2006-01-12
NO20034837D0 (no)	2003-10-29
CN1512883A (zh)	2004-07-14
TWI236908B (en)	2005-08-01
CZ20032945A3 (cs)	2004-02-18
KR20040015205A (ko)	2004-02-18
ES2255610T3 (es)	2006-07-01
IL158063A0 (en)	2004-03-28
DE60209885T2 (de)	2006-08-10
US7329667B2 (en)	2008-02-12
NZ528364A (en)	2005-12-23
NO20034837L (no)	2003-12-09
DE60209885D1 (de)	2006-05-11
BR0209035A (pt)	2004-08-10
US20040235871A1 (en)	2004-11-25

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
ATE346043T1 (de)	2006-12-15	Il-8-rezeptorantagonisten
NO20025754L (no)	2002-11-29	IL-8 Reseptor-antagonister
ATE439344T1 (de)	2009-08-15	Muscarin-antagonisten
ATE299698T1 (de)	2005-08-15	Il-8 rezeptor antagonisten
ATE469875T1 (de)	2010-06-15	Nk1-antagonisten
ATE374183T1 (de)	2007-10-15	Nk1-antagonisten
DK1261336T3 (da)	2007-06-04	IL-8-receptorantagonister
DE60130000D1 (de)	2007-09-27	Zwitterionische tachykinin-rezeptor-antagonisten
MA25739A1 (fr)	2003-04-01	Antagonistes recepteurs il-8
ATE394114T1 (de)	2008-05-15	Somatostatin-antagonisten
DK1180028T3 (da)	2007-05-21	IL-8-receptorantagonister
NO20024367D0 (no)	2002-09-12	IL-8 reseptorantagonister
NO20015774D0 (no)	2001-11-27	IL-8 reseptorantagonister
IS6818A (is)	2003-05-15	Histamín viðtaka mótlyf
DE60222015D1 (de)	2007-10-04	Ccr-3-rezeptorantagonisten vii
DE60209885D1 (de)	2006-05-11	Crf receptor antagonisten
NO20024366D0 (no)	2002-09-12	IL-8 reseptorantagonister
SE0003996D0 (sv)	2000-11-01	Receptorantagonister

Legal Events

Date	Code	Title	Description
2006-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties